TRAVERE THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number
TRAVERE THERAPEUTICS, INC. (TVTX) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number of 7.95 million shares as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber · last filed 2026-08-04
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 7.95M shares.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 9.15M shares.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 8.24M shares.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 9.54M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number |
|---|---|
| 2026-06-30 | 7.95M shares 10-Q · filed 2026-08-04 |
| 2026-03-31 | 9.15M shares 10-Q · filed 2026-05-04 |
| 2025-12-31 | 8.24M shares 10-Q · filed 2026-08-04 |
| 2025-09-30 | 9.54M shares 10-Q · filed 2025-10-30 |
| 2025-06-30 | 10.19M shares 10-Q · filed 2025-08-06 |
| 2025-03-31 | 10.20M shares 10-Q · filed 2025-05-01 |
| 2024-12-31 | 9.28M shares 10-Q · filed 2025-10-30 |
| 2014-06-30 | 4.39M shares 10-Q · filed 2014-08-14 |
| 2013-12-31 | 1.72M shares 10-Q · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |